
US biotechnology firm Moderna on Monday said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7.
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3iItHUe
No comments:
Post a Comment